Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment
- PMID: 26247958
- PMCID: PMC4588193
- DOI: 10.3390/pharmaceutics7030175
Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment
Abstract
The blood-brain barrier remains a main hurdle to drug delivery to the brain. The prognosis of glioblastoma remains grim despite current multimodal medical management. We review neurosurgical technologies that disrupt the blood-brain barrier (BBB). We will review superselective intra-arterial mannitol infusion, focused ultrasound, laser interstitial thermotherapy, and non-thermal irreversible electroporation (NTIRE). These technologies can lead to transient BBB and blood-brain tumor barrier disruption and allow for the potential of more effective local drug delivery. Animal studies and preliminary clinical trials show promise for achieving this goal.
Keywords: blood–brain barrier; focused ultrasound; glioblastoma; intra-arterial drug delivery; laser interstitial thermotherapy; non-thermal irreversible electroporation.
Figures
Similar articles
-
Blood-Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade.Curr Oncol Rep. 2024 Mar;26(3):236-249. doi: 10.1007/s11912-024-01497-7. Epub 2024 Feb 8. Curr Oncol Rep. 2024. PMID: 38329660 Review.
-
Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.Neurosurg Clin N Am. 2012 Apr;23(2):323-9, ix-x. doi: 10.1016/j.nec.2012.01.008. Epub 2012 Feb 18. Neurosurg Clin N Am. 2012. PMID: 22440875
-
Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.J Neurosurg Anesthesiol. 2007 Oct;19(4):249-56. doi: 10.1097/ANA.0b013e3181453851. J Neurosurg Anesthesiol. 2007. PMID: 17893577
-
Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood-Brain Barrier Disruption.Cancers (Basel). 2024 Jan 4;16(1):236. doi: 10.3390/cancers16010236. Cancers (Basel). 2024. PMID: 38201663 Free PMC article. Review.
-
A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.Drug Deliv. 2019 Dec;26(1):551-565. doi: 10.1080/10717544.2019.1616235. Drug Deliv. 2019. PMID: 31928355 Free PMC article. Review.
Cited by
-
Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems.Curr Neuropharmacol. 2021;19(5):693-710. doi: 10.2174/1570159X18666200807143526. Curr Neuropharmacol. 2021. PMID: 32851949 Free PMC article.
-
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials.Cancers (Basel). 2023 Jan 30;15(3):857. doi: 10.3390/cancers15030857. Cancers (Basel). 2023. PMID: 36765816 Free PMC article. Review.
-
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.Pharmaceutics. 2019 Oct 17;11(10):540. doi: 10.3390/pharmaceutics11100540. Pharmaceutics. 2019. PMID: 31627301 Free PMC article. Review.
-
Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment-An Update.Biomedicines. 2022 Jul 5;10(7):1598. doi: 10.3390/biomedicines10071598. Biomedicines. 2022. PMID: 35884903 Free PMC article. Review.
-
Strategies to target drugs to gliomas and CNS metastases of solid tumors.J Neurol. 2016 Mar;263(3):428-40. doi: 10.1007/s00415-015-7919-9. Epub 2015 Oct 17. J Neurol. 2016. PMID: 26477024 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources